Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 4, 2024

Primary Completion Date

January 30, 2025

Study Completion Date

April 10, 2025

Conditions
Cervix CancerCervix NeoplasmPrecancerous ConditionsCervical Precancer
Interventions
DRUG

Artesunate pessary

Subjects will self-administer 200 mg of Artesunate pessary (vaginal insert) daily for 5 days, on weeks 1, 3, 5, 7.

PROCEDURE

Colposcopy

Colposcopy is a procedure that allows close examination of the cervix, vagina, and vulva, performed on weeks 8 and 14.

Trial Locations (1)

Unknown

Lumumba Sub-County Hospital, Kisumu

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

UNC Lineberger Comprehensive Cancer Center

OTHER